| 邱婷 吕颐菲 金燕 王雪 李玉龙.前列腺素E1 联合糖皮质激素治疗药物性重症肝炎的临床效果*[J].现代生物医学进展英文版,2016,16(31):6103-6106. |
| 前列腺素E1 联合糖皮质激素治疗药物性重症肝炎的临床效果* |
| Clinical Effects of Prostaglandin E1 combined with Glucocorticoid Hormoneon the Treatment of Severe Hepatitis with Drugs |
| |
| DOI： |
| 中文关键词: 前列腺素E1 糖皮质激素 药物性重症肝炎 |
| 英文关键词: Prostaglandin E1 Glucocorticoid hormone Severe drugs hepatitis |
| 基金项目:陕西省科技攻关项目[2004K10-G4(1)] |
|
| Hits: 623 |
| Download times: 0 |
| 中文摘要: |
| 目的：探讨前列腺素E1 联合糖皮质激素治疗药物性重症肝炎的临床效果。方法：前瞻性研究我院药物性重症肝炎患者68
例，随机分为实验组与对照组，每组34 例。对照组患者给予糖皮质激素治疗，实验组患者给予糖皮质激素联合前列腺素E1治疗。
观察并比较治疗前后两组患者血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TBIL)水平的变化情况，以及临床疗效和并发
症的发生率。结果：与治疗前相比，两组患者治疗后血清ALT，AST，TBIL水平均降低，差异具有统计学意义（P＜0.05）；与对照组
相比，实验组患者治疗后血清ALT，AST 及TBIL水平较低，差异具有统计学意义（P＜0.05）；实验组患者并发症发生率（41.18%）
明显低于对照组（52.94%），差异具有统计学意义（P＜0.05）。实验组患者临床总有效率（91.18%）显著高于对照组（73.53%），差异
具有统计学意义（P＜0.05）。结论：前列腺素E1 联合糖皮质激素能够提高药物性重症肝炎的临床总有效率，降低并发症发病率，值
得在临床上推广应用。 |
| 英文摘要: |
| Objective:To investigate the clinical effects of prostaglandin E1 combined with glucocorticoid hormone on the treatment
of severe hepatitis with drugs.Methods:Prospective study of 68 patients with severe drugs hepatitis were collected and randomly
divided into the experiment group and the control group, with 34 cases in each group. The patients in the control group were treated with
glucocorticoid hormone, while the patients in the experiment group were treated with the glucocorticoid hormone and prostaglandin E1.
Then the serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL), and the clinical
effective rate and incidence of complications in the two groups. Were observed and compared between the two groups.Results:Compared
with before treatment, the serum levels of ALT, AST and TBIL in the two groups decreased after the treatment, and the differences
were statistically significant (P<0.05); Compared with the control group after the treatment, the serum levels of ALT, AST and TBIL in
the experiment group were lower, and the differences were statistically significant (P<0.05); The incidence of complications in the experiment
group was 41.18%, which was lower than 52.94%in the control group, and the difference was statistically significant (P<0.05); The
total effective rate in the experiment group was 91.18%, which was higher than 73.53%in the control group, and the difference was statistically
significant (P<0.05).Conclusion:Prostaglandin E1 combine with glucocorticoid hormone has better effects on the treatment of severe
hepatitis induced by drugs, which can improve the total effective rate and reduce the incidence of complications, and it is worthy of
clinical application. |
|
View Full Text
View/Add Comment Download reader |
| Close |
